← Companies|Karolinska Inst
Ka

Karolinska Inst

NPStockholm SEFounded 18106,000 employees
Private CapacadPrivateOncologyNeurology
Platform: Research Univ
Market Cap
N/A
All Drugs
2
Clinical Trials
2
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
KAR-IIT-192KAR-IIT-192Phase 31VaccineCDK4/6BETiFabry
KAR-IIT-216KAR-IIT-216Phase 11ERTMeninPCSK9iADHD
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (2)
2027-06-03
KAR-IIT-192 Ph3 Readout
Fabry
Ph3 Readout
2027-08-06
KAR-IIT-216 Interim
ADHD
Interim